SPAAR and breast cancer: Evaluation of the LINC00961 expression among 12 breast cancer categories, including 1910 luminal A and B samples, across Affymetrix Human Genome U133 Plus 2.0 Array platform demonstrated that LINC00961 was downregulated in BC categories compared with normal breast samples (Additional file 2).